Moreover, MM134, -6, -7, and -9 exhibited pro-apoptotic activity in BxPC-3 and PC-3 cells and are predicted to act through inhibition of AKT-mTOR and PD-1/PD-L1 pathways in cancer cells, as indicated by in silico results [19]. This evidence concerns the gene CD274 and cancer.